Concepedia

Kevin Kelnar

KK

20

Publications

7.7K

Citations

18

H-Index

2005

Active since

Affiliations

Mirna Therapeutics (United States)(Current)

Asuragen (United States)

The University of Texas MD Anderson Cancer Center

Woodward (United States)

Yale University

Kevin Kelnar is an author at Mirna Therapeutics (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2005–2020

20

Publications

20

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Can Liu, Kevin Kelnar, Bigang Liu et al. · Nature Medicine · 2011 · 1.4K citations · Full text

, , +11

The <i>let-7</i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

Charles D. Johnson, Aurora Esquela‐Kerscher, Giovanni Stefani et al. · Cancer Research · 2007 · 1.2K citations · Full text

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

John Cogswell, James M. Ward, Ian A. Taylor et al. · Journal of Alzheimer s Disease · 2008 · 925 citations

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 850 citations · Full text

Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

Jason F. Wiggins, Lynnsie Ruffino, Kevin Kelnar et al. · Cancer Research · 2010 · 686 citations · Full text

Rows per page

1–5 of 20